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Abstract
In the past decades several definitions of oral leukoplakia have been proposed, the last one, being authorized by 
the World Health Organization (WHO), dating from 2005. In the present treatise an adjustment of that definition 
and the 1978 WHO definition is suggested, being :  “A predominantly white  patch or plaque that cannot be char-
acterized clinically or pathologically as any other disorder; oral leukoplakia carries an increased risk of cancer 
development either in or close to the area of the leukoplakia or elsewhere in the oral cavity or the head-and-neck 
region”. Furthermore, the use of strict diagnostic criteria is recommended for predominantly white lesions for 
which a causative factor has been identified, e.g. smokers’ lesion, frictional lesion and dental restoration associat-
ed lesion. A final diagnosis of such leukoplakic lesions can only be made in retrospect after successful elimination 
of the causative factor within a somewhat arbitrarily chosen period of 4-8 weeks. It seems questionable to exclude 
“frictional keratosis” and “alveolar ridge keratosis” from the category of leukoplakia as has been suggested in 
the literature.  Finally, brief attention has been paid to some histopathological issues that may cause confusion in 
establishing a final diagnosis of leukoplakia. 
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Introduction
1. The definition and terminology of oral leukoplakia 
and leukoplakialike (“leukoplakic”) lesions and dis-
orders of the oral mucosa is the subject of discussion 
in the literature for many decades. This discussion is 
mainly focused on clinical aspects, but is partly related 
to some histopathological aspects as well. In this trea-
tise the various definitions of oral leukoplakia will be 
discussed, resulting in a suggestion for a slight adjust-
ment of the 2005 WHO definition. Furthermore, some 
leukoplakic lesions will be discussed that may cause 
some confusion as whether or not to exclude them from 
the category of leukoplakia; examples are “alveolar 
ridge keratosis” and “frictional keratosis”.
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Definition
2.1 The various WHO definitions and suggestion for an 
adjusted definition
In 1978, oral leukoplakia has been defined by the World 
Health Organization  (WHO) as: ‘A white patch or plaque 
that cannot be characterized clinically or pathologically 
as any other disease’ (1). In an explanatory note it has 
been explicitly stated that the term leukoplakia is unre-
lated to the absence or presence of epithelial dysplasia. 
In a monograph by the WHO, published in 1997, the 
phrase: ‘any other definable disease’ was replaced by 
‘any other definable lesion’ (2). No justification has been 
provided for this change. 
In 2002, it has been recommended to make a distinction 
between a provisional clinical diagnosis of oral leuko-
plakia and a definitive one (Table 1) (3). A provisional 
diagnosis was made when a lesion at the initial clinical 
examination could not be clearly diagnosed as either leu-
koplakia or any other disease. In case of a provisional 
clinical diagnosis, Certainty factor 1 was assigned (Ta-
ble 2). A definitive clinical diagnosis of leukoplakia was 
made after unsuccessful elimination of suspected etio-
logical factors or in the absence of such factors, assigning 
Certainty factor 2. Certainty factor 3 was assigned when 
histopathological examination of an incisional biopsy did 
not show the presence of any other diseases. In case of an 
excisional biopsy or surgical excision, performed after an 
incisional biopsy, Certainty factor 4 was assigned based 
on histopathological examination of the surgical speci-
men (Fig. 1). It goes without saying that in epidemiologi-
cal studies a Certainty factor 1, based on a single oral 
examination, is acceptable, while in scientific studies, 
e.g. comparing different treatment results, Certainty fac-
tor 4 will be required, if feasible. Apparently, the recom-
mendation to use a Certainty factor has not been widely 
accepted in the recent literature (4), although the use of 
such factor is common practice in cancer registries.
In 2005, the definition of oral leukoplakia has been 
changed at a  WHO supported meeting into: ‘A white 
plaque of questionable risk having excluded (other) 
known diseases or disorders that carry no increased risk 
for cancer’ (5). During the latter meeting it has deliber-
ately been decided to consider leukoplakia a potentially 
malignant- premalignant and precancerous are equiva-
lent adjectives-  disease and not a lesion since it is well 
known that cancer development not always occurs in or 
close to the leukoplakia but may also occur at other sites 
in the oral cavity or the head-and-neck region.
 
DIAGNOSIS OF ORAL LEUKOPLAKIA 
 (Provisional clinical diagnosis, C 1*) 
 
 
 
   
 Consider the taking of a biopsy, particularly in case of symptoms No possible cause(s) 
  (Definitive clinical diagnosis, C 2) 
  
 In the absence of dysplasia 
 
 
 Elimination of possible cause(s), such as mechanical irritation, amalgam restoration   
 in direct contact with the white lesion, fungal infection, and tobacco habits  
 (maximum 4-8 weeks to observe the result)  
 
 
 
 
  No response    Biopsy 
     
   (Definitive clinical diagnosis, C 2) 
    
      
    
  
    
 Good response Definitive clinicopathological diagnosis  
  C 3 (in case of incisional biopsy only  
  C 4 (in case of excisional biopsy or surgical 
 excision after an incisional biopsy  
 
 
 
 
Definable lesion Non-dysplastic leukoplakia Dysplastic leukoplakia Definable lesion  
     
 
* C=Certainty factor (see table 2) 
Table 1. Diagnosis of oral leukoplakia.
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Although various international meetings on the sub-
ject of oral leukoplakia  have been held between 1978 
(WHO) and 2005 (WHO) no substantial changes in the 
definition of leukoplakia have resulted from these meet-
ings.
In the sixties of the past century a minimum size of 5 
mm was required before being allowed to use the term 
leukoplakia (6). There seems no strong reason to re-
introduce a minimum size, since cancer devopment 
may also take place in very small leukoplakias. Another 
part of previous definitions of leukoplakia has been the 
requirement of a non-removable nature of the white le-
sion, apparently mainly meant to separate pseudomem-
branous candidiasis from leukoplakia. The adjectives 
“non-removable” or “non-scrapable” seem, indeed, to 
have some practical value, but there is no strong reason 
to include these in the definition.
The advantage of the 2005 WHO definition above the 
one from 1978 is its statement about the behaviour of 
oral leukoplakia (“questionable risk”). Unfortunately, in 
both WHO definitions (1978 and 2005) the diagnosis of 
leukoplakia is one by exclusion (of other “known dis-
eases or disorders”).  A list of these “known diseases” 
is depicted in table 3. Some of these diseases will be 
briefly commented upon (see ad 3). Many, if not most, 
of the listed entities may be easy to distinguish from 
leukoplakia by an experienced clinician, either based on 
the history or based on the clinical appearance, but this 
may not be the case for the less experienced clinician, 
being either a dentist, an oral and maxillofacial surgeon, 
an otolaryngologist or a dermatologist.  Furthermore, it 
does not seem realistic to expect family doctors to be 
knowledgable in this field, since probably in most parts 
of the world little attention is paid to oral diseases dur-
ing the medical curriculum. One may even discuss at 
what level dentists-general practitioners should be edu-
cated in the diagnosis and management of the numerous 
lesions and disorders of the oral mucosa . 
A combination of  the 1978 and the 2005 WHO defi-
nitions of oral leukoplakia may result in the following 
text: “A predominantly white  patch or plaque that can-
not be characterized clinically or pathologically as any 
other disorder; oral leukoplakia carries an increased risk 
of cancer development either in or close to the area of 
leukoplakia or elsewhere in the oral cavity or the head-
and-neck region”. 
2.2 What is a significant  increased risk of cancer de-
velopment?
In defining a potentially malignant disorder it is usu-
ally stated that there is “significant increased risk” of 
cancer development, without specifying “significant”. 
When the incidence- number of new patients per year- 
of oral cancer is set at a low 2:100,000 population and 
the annual malignant transformation rate of leukoplakia 
at 2:100 (irrespective of the discussion whether or not 
treatment of leukoplakia reduces the risk of malignant 
transformation) there is a thousandfold risk in leukopla-
kia patients to develop cancer in comparison with pa-
tients not having leucoplakia. Probably, a thousandfold 
increased risk is perceived, particularly by patients, as 
being significant.
Discussion on some “other known diseases and 
disorders” that may have a leukoplakic appear-
ance
-3.1 Alveolar ridge “keratosis”
A few papers have been devoted to “alveolar ridge kera-
tosis” (7,8). Apparently, the supposed cause of the lesion 
is chronic frictional (masticatory) trauma to the max-
 1 
C1 Evidence from a single visit, applying inspection and palpation as the only diagnosis means (Provisional clinical 
diagnosis), including a clinical picture of the lesion. 
C2 Evidence obtained by a negative result of elimination of suspected etiologic factors, e.g. mechanical irritation, during a 
follow-up period of 6 weeks (Definitive clinical diagnosis) 
C3 As C2, but complemented by pretreatment incisional biopsy in which, histopathologically, no definable lesion is 
observed (Histopathologically supported diagnosis)  
C4 Evidence following surgery and pathologically examination of the resected specimen 
 
Table 2. Certainty (C)-factor of a diagnosis of oral leukoplakia.3.
Fig. 1. Leukoplakia (or "benign alveolar ridge keratosis"?) in both 
sides of the maxilla in a patient who never smoked and has not been 
wearing a partial denture.
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illary and mandibular alveolar ridges. Histopathologi-
cally, almost of all these lesions show hyperkeratosis 
without epithelial dysplasia. The suggestion has been 
made in both previous papers to remove this lesion 
from oral leukoplakia, mainly based on the assumption 
that malignant transformation is extremely rare (Fig. 1). 
There are not many follow-up studies that focused on 
leukoplakia of the alveolar ridges only. Therefore, there 
is some reluctance to accept the suggestion to remove 
this lesion from leukoplakia. 
In one paper on this subject it was noted that alveolar 
ridge keratosis resembles chronic lichen simplex of the 
skin, apparently being caused by chronic frictional in-
jury (8). Therefore, the authors suggested the somewhat 
confusing term “oral lichen simplex chronicus” as a 
synonym.
There may be some overlap with the reported frictional 
keratosis of the facial (buccal) attached gingiva to be 
discussed in 3.3
-3.2 Candidiasis, hyperplastic type
There is some room for discussion, both clinically and 
histopathologically,  about the diagnosis of hyperplas-
tic candidiasis versus Candida-associated leukoplakia, 
particularly if located at the commissures of the lips, the 
hard palate and the dorsal surface of the tongue. If such 
lesions disappear after antifungal treatment within an 
arbritarily chosen period of 4-8 weeks there is no jus-
tification to call such lesions leukoplakias any longer. 
Table 3.  Definable white diseases and disorders that may have a leukoplakic appearance.
Lesion Main diagnostic criteria 
  Alveolar ridge "keratosis" * Primarily a clinical diagnosis of a flat, white aspect of the mucosa of an edentulous part of the alveolar 
ridge; may overlap Frictional "keratosis" 
  Aspirin burn History of prolonged local application of aspirin tablets (paracetamol may cause similar changes) 
  Candidasis, pseudomembranous Clinical aspect (pseudomembranous, often symmetrical pattern) 
 hyperplastic* Somewhat questionable entity; some refer to this lesion as candida associated leukoplakia 
 Darier-White diseases Associated with lesions of the skin and the nails; rather typical histopathology 
 Frictional "keratosis"* Disappearance of the lesion within an arbitrarily chosen period of 4-8 weeks after elimination of the 
suspected mechanical irritation (e.g. habit of vigorous toothbrushing); therefore, it is a retrospective 
diagnosis only 
  Geographic tongue Primarily a clinical diagnosis; characterized by a wandering pattern in time 
  Glassblowers lesion Occurs only in glassblowers; disappears within a few weeks after cessation of glassblowing 
  Hairy leukoplakia* Clinical aspect (bilateral localization on the borders of the tongue); histopathology (incl. EBV) 
  Lesion caused by a dental restoration (often amalgam)* Disappearance of the anatomically closely related (amalgam) restoration within an arbitrarily chosen 
period of 4-8 weeks after its replacement; therefore, it is a retrospective diagnosis only 
  Leukoedema Clinical diagnosis (incl. symmetrical pattern) of a veil-like aspect of the buccal mucosa 
  Lichen planus, reticular type and erythematous type Primarily a clinical diagnosis (incl. symmetrical pattern); histopathology is not diagnostic by its own 
  Linea alba Clinical aspect (located on the line of occlusion in the cheek mucosa; almost always bilateral) 
  Lupus erythematosus Primarily a clinical diagnosis (incl. symmetrical pattern); almost always cutaneous involvement as well. 
Histopathology is not diagnostic by its own 
Morsicatio (habitual chewing or biting of the cheek, tongue, lips) History of habitual chewing or biting; clinical aspects 
  Papilloma and allied lesions, e.g. condyloma acuminatum,          Clinical aspect; medical history; HPV typing of a biopsy may be helpful.  
multifocal epithelial hyperplasia, squamous papilloma,   
  verruca vulgaris 
  Skin graft, e.g. after a vestibuloplasty History of a previous skin graft 
  Smokers' lesion* Disappearance of the lesion within an arbitrarily chosen period of 4-8 weeks after cessation of the 
tobacco habits; therefore, it is a retrospective diagnosis only 
Smokers' palate ('stomatitis nicotinica') Clinical aspect; history of smoking 
Syphilis, secondary ('mucous patches') Clinical aspect; demonstration of T. pallidum; serology 
Verrucous hyperplasia and verrucous carcinoma                                                                 Primarily histopathological entities 
White sponge nevus Family history; clinical aspect (often symmetrical pattern) 
*These entities will be briefly discussed in the text. 
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However, in case of persistence, it seems safe practice 
to consider a diagnosis of Candida-associated leukopla-
kia.
-3.3 Frictional “keratosis” 
Another possible reversible white lesion is the frictional 
lesion caused by mechanical irritation, e.g. vigorously 
brushing of the teeth (Fig. 2). This lesion is sometimes 
Fig. 2. Leukoplakia (or "frictional keratosis"?) in a 57-year-old wom-
an.
referred to as “frictional keratosis”. The term “lesion” is 
preferred because “keratosis” is actually a histopatho-
logical term.  There may be some overlap with the pre-
viously discussed alveolar ridge keratosis (see ad 3.1). 
The suggestion to remove this lesion- particularly when 
located on the buccal attached gingiva- from the cat-
egory of leukoplakia seems rather questionable (9).  A 
final diagnosis of frictional lesion can only be applied to 
cases where the lesion has disappeared after elimination 
of the possible mechanical cause- provided that there 
are no symptoms that would require to immediately  bi-
opsy the lesion- , within a somewhat arbitrarily chosen 
period of no more than 4-8 weeks. In other words, a de-
finitive diagnosis of frictional lesion can only be made 
in retrospect.
-3.4 Hairy leukoplakia
The term hairy leukoplakia is a misnomer- but well ac-
cepted in the literature- for various reasons, being 1) it 
is a well described entity, particularly by the immuno-
histochemical demonstration of EBV DNA in the koilo-
cytic epithelial cells of a biopsy specimen, 2) it is not a 
potentially malignant disorder, and 3) the clinical aspect 
is not always “hairy”. Admittedly, it is difficult to come 
up with a better term (10).
-3.5 Restoration associated lesion
A somewhat similar approach as discussed above with 
regard to frictional lesions is valid in case of a provision-
al diagnosis of a “contact lesion”, supposedly caused by 
direct prolonged contact by large amalgam restorations, 
particularly in case of a buccal or lingual extension. A 
final diagnosis of amalgam associated lesion should 
only be applied when the lesion has disappeared after 
replacement or removal of the amalgam restoration- 
provided that there are no symptoms that would require 
to immediately  biopsy the lesion- , within a somewhat 
arbitrarily chosen period of no more than 4-8 weeks. 
Therefore, a definitive diagnosis of amalgam associated 
lesion can only be made in retrospect.
-3.6 Smokers’ lesion versus tobacco associated leuko-
plakia
It is well known that leukoplakia in patients with to-
bacco habits might be reversible if patients give up their 
smoking habits (11).  In the absence of symptoms, be-
ing a strong indication for an immediate biopsy in order 
to exclude the presence of severe epithelial dysplasia 
or even squamous cell carcinoma,  the patient should 
be advised to give up the tobacco habit. If successful 
and if the white lesion regresses within a somewhat ar-
bitrarily chosen period of no more than 4-8 weeks the 
provisional clinical diagnosis of such lesion should, in 
retrospect, be changed into “smokers’ lesion”. When the 
patient is not able or willing to give up the tobacco habit 
and in case of persistence of the leukoplakia, the term 
“tobacco-associated leukoplakia” can be applied, irre-
spective of the relevance of such designation.
Clinical classification of leukoplakia with em-
phasis on (proliferative) verrucous leukoplakia.
4 1. Traditionally, two major clinical types of leukopla-
kia are recognized, being the homogeneous and the non-
homogeneous type respectively. The significance of this 
classification is the assumption that there is a correla-
tion between the clinical type and the risk of malignant 
transformation, the non-homogeneous type carrying a 
higher risk. In some studies there is such correlation 
while in other studies there is not.
The homogeneous type is characterized by a thin, flat 
and homogeneous whitish appearance (Fig. 3). The 
non-homogeneous type is subdived in a variety of sub-
types, such as speckled or erythematous (white and red 
changes),  also referred to as erythroleukoplakia (Fig. 
4), nodular (Fig. 5) and verrucous (Fig. 6). Particularly 
the verrucous type is probably quite often misdiag-
nosed by clinicians because of its homogeneous white 
appearance and its often homogeneous (verrucous) tex-
ture. There are actually no strict criteria how to make 
a distinction clinically between verrucous leukoplakia 
and verrucous carcinoma. 
Another confusing type is the proliferative verrucous 
leukoplakia (PVL), as being introduced in the literature 
by Hansen et al. (12). In the original publication PVL 
has been characterized as a slow-growing, persistent, 
and irreversible lesion, resistant to all forms of therapy 
as recurrence is the rule. PVL may start as a simple 
keratosis at one end to invasive carcinoma at the other.
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In fact, a diagnosis of PVL can only be made in retro-
spect. In several of such cases the initial lesion may just 
be a solitary homogeneous or non-homogeneous leuko-
plakia (13). Unfortunately, in many scientific reports on 
PVL just multifocality and involvement of the gingiva 
seem to have been used as diagnostic criteria without 
paying attention to the history of the disease.
Some histopathological areas of confusion
-5.1 The assessment of epithelial dysplasia
It is well recognized that the assessment of the presence 
and degree of epithelial dysplasia carries a substantial 
degree subjectivity, reflected in a distinct intra- and in-
terobserver variation (14-16). Unfortunately, in spite of 
numerous attempts, as being suggested in the literature, 
there is no international consensus on this issue.
Probably some pathologists will deny a diagnosis of 
leukoplakia in the absence of epithelial dysplasia, what 
is not in accordance with the recommendations from 
the “dental” literature.
-5.2 Lichenoid dysplasia
In 1985  the supposedly distinct entity of lichenoid dys-
plasia has been introduced in the literature (17).  The 
use of of this term is discouraged since it, erroneously, 
may suggest dysplastic changes occurring in oral li-
chen planus. Probably a number of the reported cases 
of malignant transformation of lichen planus are caused 
by forementioned confusing terminology, while cases 
of leukoplakia with a lichenoid appearance histopatho-
logically, mainly consisting of a subepithelial bandlike 
infiltrate, may have erroneously been reclassified as li-
chen planus. 
-5.3 Verrucous hyperplasia versus verrucous carcino-
ma
Fig. 3. Homogeneous (flat and thin) leukoplakia in a 53-year-old 
man.
Fig. 4. Non-homogeneous (white and red changes, also referred to as 
erythroleukoplakia) in an 88-year-old woman.
Fig. 5. Non-homogeneous, nodular, leukoplakia in a 61-year-old 
man.
Fig. 6. Non-homogeneous, verrucous leukoplakia. In spite of a ho-
mogeneous white appearance and a homogeneous verrucous texture, 
this lesion should not be called homogeneous leukoplakia
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Several papers have been published about the his-
topathological difference between verrucous hyper-
plasia and verrucous carcinoma, still leaving room for 
discussion (18,19). In daily practice it is difficult, if not 
impossible,  to make this distinction in a reproducible 
way. Besides, one may question the clinical relevance of 
the distinction between these two entities since for both 
lesions (surgical) removal is recommended. A pitfall is 
that some pathologists may describe these  epithelial 
changes as being benign, while the behavior of such le-
sions actually is unpredictable.
Discussion and Conclusions
It is well appreciated that a number of aspects of the 
presently discussed definition and terminology may not 
be equally valid in all parts of the world. A classifica-
tion of potentially malignant disorders has been  pro-
posed in 2011 from India (20). Apparently, this classi-
fication is not limited to leukoplakia, but also includes 
entities such as lichen planus, oral submucous fibrosis, 
nutritional deficiencies and some inherited cancer syn-
dromes.
The recommendation is made to modify the present 
2005 WHO definition of oral leukoplakia, amongst oth-
ers by adding explicitly  the requirement of histopatho-
logic examination in order to obtain a definitive clin-
icopathological diagnosis.  As a result, the following 
definition is proposed: “A predominantly white  patch 
or plaque that cannot be characterized clinically or 
pathologically as any other disorder; oral leukoplakia 
carries an increased risk of cancer development either 
in the area of the leukoplakia or elsewhere in the oral 
cavity or the head-and-neck region”. 
Furthermore, the use of strict diagnostic criteria is rec-
ommended for predominantly white lesions or diseases 
for which a possible causative factor has been identified, 
e.g. smokers’ lesion, frictional lesion and dental resto-
ration associated lesion. An observation of 4-8 weeks 
after  removal of the suggested cause seems a practical 
one and seems also safe practice, particularly in case of 
an asymptomatic leukoplakic disorder. In this respect 
one should realize that at the first visit of a patient with 
oral leukoplakia a squamous cell carcinoma may be 
present already and one would not run the risk of ob-
serving such event for a period of more than 4-8 weeks. 
Even such period is already a long one in case of a sq-
uamous cell carcinoma, a carcinoma in situ or severe 
epithelial dysplasia. However, it should be emphasized, 
that the presence of such changes is nearly always as-
sociated with symptoms. Therefore, in the presence of 
symptoms a biopsy is strongly recommended before 
elimination of possibly causative factors and observa-
tion of the result of such elimination.
As is true for almost all pathologies proper communica-
tion between clinicians and pathologists is important, 
particularly in the field of oral potentially malignant 
disorders. For instance, some pathologists will deny 
a diagnosis of leukoplakia in the absence of epithelial 
dysplasia. Also the use of the term “lichenoid dysplasia” 
may be the subject of confusion between pathologists 
and clinicians.
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